Study could lead towards a personalised medicine for chemoresistant lymphomata

[News]

To date, tests have only been carried out on cells, but a piece of research conducted by the Department of Genetics at the UPV/EHU's Faculty of Medicine in collaboration with MD Anderson and the CNIO is opening up the door for the treatment of lymphoma types that have a lower survival rate. The study of the molecular characteristics of the tumours would enable molecules that are altered in a specific way to be identified and turned into new therapeutic targets that would improve the prognosis of patients with chemoresistant lymphomata.

More... (http://www.news-medical.net/news/20131216/Study-could-lead-towards-a-personalised-medicine-for-chemoresistant-lymphomata.aspx)